William Skipworth, Forbes Staff

Author's posts

Hotter Temperatures From Climate Change Could Increase Drug And Alcohol Hospitalizations, Researchers Suggest

A new study from Columbia University researchers found that during higher temperatures, hospitals see a larger number of drug- and alcohol-related admissions—leading t…

Researchers Develop Algorithm To Predict Whether A Person Gets Long Covid

Researchers with Mount Sinai Hospital and Yale University say they’re the first to identify specific blood biomarkers that can accurately identify long Covid—allowing …

Doctors Transplant Pig Heart Into Dying Man—Only The Second Time It’s Ever Been Done

Doctors hope this new procedure could be a game changer in the organ transplant field.

Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death

The study found Paxlovid is now less effective at keeping patients out of the hospital, but still remains highly effective at stopping death.

Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign

Popular novelist and YouTuber John Green as well as international health nonprofits had been running a weeklong pressure campaign against the company.

Sitting Around For Too Many Hours Can Boost Your Dementia Risk—Here’s What Researchers Recommend

A new study found that people with too much sedentary time have an increased risk of developing dementia.

Scientists Finally Discover Why Exercise Cuts Alzheimer’s Risk, Study Says

Researchers have identified a hormone called irisin that reduces a protein widely believed to cause Alzheimer’s disease—more proof that the best known way to combat the disease is by staying active.

Here’s What Vaccines Your Child Will Need Before School Starts

Each state has different school vaccinations requirements, but many vaccines are required across the country.

NIH Opens Clinical Trials For Long Covid Treatment

The trials are part of the world’s largest effort to understand, treat and prevent long Covid.

Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries

The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson’s tuberculosis drug in 44 more countries.